XML 53 R39.htm IDEA: XBRL DOCUMENT
v3.25.1

Warrants (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Warrants |
Schedule of warrants issued with financing |
Schedule of warrants issued with financing |  |  |  |  |  |
Type |  | Number |  | Exercise Price |  | Expiry Date
2022 Pre-Funded Warrants |  | 1,846 |  | $2.00 |  | Unlimited
Tradeable Warrants |  | 2,051 |  | $4,440.00 |  | February 2027
Investor Warrants |  | 1,801 |  | $4,440.00** |  | March 2027
April Warrants |  | 4,862 |  | $7,520.00 |  | April 2027
May Pre-Funded Warrants |  | 1,751 |  | $2.00 |  | Unlimited
May Investor Warrants |  | 5,952 |  | $1,180.00 |  | November 2028
2024 Pre-Funded Warrants |  | 22,500 |  | $2.00 |  | Unlimited
Series A Warrants |  | 3,986* |  | $4,200.00* |  | August 2026
Series B Warrants |  | 7,973* |  | $4,760.00* |  | February 2029
| * | Subject to adjustments per the Series A and Series B Warrant Agreements. The Series B Warrants adjusted to a total of 13,613,297 warrants exercisable at $2.7879 per warrant following the Company’s 1-for-20 reverse stock split on August 8, 2024.
| ** | Subject to adjustment.
Schedule of warrants outstanding |
Schedule of warrants outstanding |  |  |  |  |  |
Type |  | Number |  | Exercise Price |  | Expiry Date
Tradeable Warrants |  | 482 |  | $220.00 |  | February 2027
Investor Warrants |  | 400 |  | $4,000.00** |  | March 2027
Series B Warrants |  | 12,353,992* |  | $2.7879* |  | February 2029
| * | As adjusted and subject to further adjustments. In a subsequent event on January 3, 2025, 127,443 Series B Warrants were exercised leaving 12,226,549 warrants remaining outstanding.
| ** | As adjusted.

X
- References No definition available. + Details
Name: | SBFM_DisclosureWarrantsAbstract
Namespace Prefix: | SBFM_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | SBFM_WarrantsIssuedWithFinancingTableTextBlock
Namespace Prefix: | SBFM_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration